Evidence map›Paper›PMID 26789264›Full record

ArticlePloS one2016

Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice.

Yasuyo Urasaki, Giuseppe Pizzorno, Thuc T Le

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The Role of Uridine in Health and Disease.Journal of inflammation research · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Uridine alleviates high-carbohydrate diet-induced metabolic syndromes by activatingAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. PMPeerJ · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yasuyo UrasakiDepartment of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, Nevada, 89135, United States of America.
Giuseppe PizzornoDesert Research Institute, 10530 Discovery Drive, Las Vegas, Nevada, 89135, United States of America.
Thuc T LeDepartment of Biomedical Sciences, College of Medicine, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, Nevada, 89135, United States of America.
Roseman University of Health Sciences · USDesert Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uridine is a pyrimidine nucleoside that exerts restorative functions in tissues under stress. Short-term co-administration of uridine with multiple unrelated drugs prevents drug-induced liver lipid accumulation. Uridine has the ability to modulate liver metabolism; however, the precise mechanism has not been delineated. In this study, long-term effects of uridine on liver metabolism were examined in both HepG2 cell cultures and C57BL/6J mice. We report that uridine administration was associated with O-GlcNAc modification of FOXO1, increased gluconeogenesis, reduced insulin signaling activity, and reduced expression of a liver-specific fatty acid binding protein FABP1. Long-term uridine feeding induced systemic glucose intolerance and severe liver lipid accumulation in mice. Our findings suggest that the therapeutic potentials of uridine should be designed for short-term acute administration.

Indexed as

Fatty LiverGlucose IntolerancePrediabetic StateAnimalsForkhead Box Protein O1Forkhead Transcription FactorsGluconeogenesisHep G2 CellsHumansMiceUridineForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseUridine

Identifiers

PMID26789264
PMCPMC4720477
OpenAlexW2322314453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.